Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00731) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
JHW-015
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4275754"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Arachidonate 5-lipoxygenase (ALOX5) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway. J Biol Chem. 2013 May 10;288(19):13551-62. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.